The treatment of HIV-infected people within prison poses a significant challenge. A minimum of 5 percent of the HIV infected people in the United States are incarcerated (1,2) and a significant proportion of these have a history of drug, and/or alcohol dependence (13). Preliminary observations suggest that HIV-infected prison inmates have much higher AIDS-related mortality than matched populations outside of prison (3). Although highly active antiretroviral therapy (HAART) holds great promise in improving important clinical outcomes, difficulties with adherence appear to play a significant role in treatment failure. Directly observed therapy (DOT) is a potential mechanism to promote adherence. In the North Carolina Department of Corrections, all inmates on HAART receive HIV protease inhibitors by DOT. Although DOT is an attractive strategy, neither the level of adherence to HAART in prison nor the efficacy of DOT has been extensively evaluated. Our preliminary studies demonstrate that DOT has significant untoward effects for inmates and may be of limited utility in promoting adherence in a prison setting. The potential for a dramatic virologic response as well as the consequences of inadequate adherence for both the individual inmate and for transmission of resistant viruses makes an understanding of the adherence in this setting especially urgent. In a collaborative effort between investigators at the Centers for AIDS Research of UNC and UCLA, we will perform a comprehensive assessment of DOT among inmates with a history of substance abuse. We will determine the impact of a history of substance abuse on adherence and access to appropriate antiretroviral therapy. We will also evaluate the effect of a comprehensive adherence-enhancing intervention and document the associations among adherence, treatment failure, and the development of resistance. Specifically, we will:
Aim 1. Characterize adherence to HAART among antiretroviral-naive inmates with a history of drug and/or alcohol use incarcerated in the North Carolina Department of Corrections.
Aim II. Characterize the effect of a history of drug and/or alcohol use on adherence and the access of inmates to optimal antiretroviral therapy.
Aim III. Define the relationship between adherence and viral load in antiretroviral-naive inmates.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA013826-02
Application #
6379133
Study Section
Special Emphasis Panel (ZDA1-MXV-P (17))
Program Officer
Lambert, Elizabeth
Project Start
2000-09-30
Project End
2004-08-31
Budget Start
2001-09-01
Budget End
2002-08-31
Support Year
2
Fiscal Year
2001
Total Cost
$540,250
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Erlen, Judith A; Tamres, Lisa K; Reynolds, Nancy et al. (2015) Assessing usual care in clinical trials. West J Nurs Res 37:288-98
Petersen, Maya L; LeDell, Erin; Schwab, Joshua et al. (2015) Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring. J Acquir Immune Defic Syndr 69:109-18
White, Becky L; Golin, Carol E; Grodensky, Catherine A et al. (2015) Effect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study. AIDS Behav 19:128-36
Simoni, Jane M; Huh, David; Wang, Yan et al. (2014) The validity of self-reported medication adherence as an outcome in clinical trials of adherence-promotion interventions: Findings from the MACH14 study. AIDS Behav 18:2285-90
Rosen, M I; Black, A C; Arnsten, J H et al. (2013) Association between use of specific drugs and antiretroviral adherence: findings from MACH 14. AIDS Behav 17:142-7
Wilson, Ira B; Bangsberg, David R; Shen, Jie et al. (2013) Heterogeneity among studies in rates of decline of antiretroviral therapy adherence over time: results from the multisite adherence collaboration on HIV 14 study. J Acquir Immune Defic Syndr 64:448-54
Liu, Honghu; Wilson, Ira B; Goggin, Kathy et al. (2013) MACH14: a multi-site collaboration on ART adherence among 14 institutions. AIDS Behav 17:127-41
Simoni, Jane M; Huh, David; Wilson, Ira B et al. (2012) Racial/Ethnic disparities in ART adherence in the United States: findings from the MACH14 study. J Acquir Immune Defic Syndr 60:466-72
Genberg, Becky L; Wilson, Ira B; Bangsberg, David R et al. (2012) Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America. AIDS 26:1415-23
Wagner, Glenn J; Goggin, Kathy; Remien, Robert H et al. (2011) A closer look at depression and its relationship to HIV antiretroviral adherence. Ann Behav Med 42:352-60

Showing the most recent 10 out of 13 publications